What over‑the‑counter nasal spray brands (with generic names) are recommended for allergic rhinitis?

Common OTC Nasal Sprays for Allergic Rhinitis

For allergic rhinitis, intranasal corticosteroid sprays (INCS) such as fluticasone propionate (Flonase) and triamcinolone (Nasacort) are the most effective first-line OTC nasal treatments available.

First-Line Recommendation: Intranasal Corticosteroids

INCS remain the gold standard for allergic rhinitis treatment, particularly for moderate-to-severe symptoms 1, 2. The most commonly available OTC brands include:

• Fluticasone propionate (Flonase Allergy Relief)
• Triamcinolone acetonide (Nasacort Allergy 24HR)
• Budesonide (Rhinocort Allergy)

These medications provide superior symptom control compared to oral antihistamines and are recommended as first-line therapy 1. INCS should continue being prescribed as first-line therapy in patients with moderate-to-severe rhinitis 1.

Important Caveat About Onset

One critical pitfall: INCS take several hours to a few days to achieve full effect (though ciclesonide has faster onset) 1. Patients must understand this delayed onset to maintain adherence and not prematurely discontinue treatment.

Alternative OTC Option: Intranasal Antihistamines

While less commonly available OTC in all markets, azelastine (Astepro Allergy) is an intranasal antihistamine that:

• Works within minutes 1
• Is less effective than INCS alone 1, 2
• Can be used when rapid symptom relief is needed

Combination Therapy for Moderate-to-Severe Disease

For patients with moderate-to-severe symptoms, the combination of INCS + intranasal antihistamine is more effective than INCS alone 1, 2. The most studied combination is:

• Fluticasone propionate + azelastine (available as Dymista, though this is prescription-only in most markets)

This combination showed clinically meaningful symptom reduction (40% greater improvement than either agent alone) and works within minutes while providing sustained control 2.

Evidence Strength

Multiple trials demonstrated symptom score reductions of -5.31 to -5.7 for combination therapy versus -3.84 to -5.1 for fluticasone alone 2. However, the recommendation for combination therapy is graded as weak due to concerns about study bias and cost considerations 2.

What NOT to Use Long-Term

Avoid prolonged use of OTC nasal decongestants (oxymetazoline/Afrin, phenylephrine) beyond 3 days 3. These cause rebound congestion (rhinitis medicamentosa) and have no role in allergic rhinitis management beyond short-term use to allow other medications to penetrate effectively.

Adjunctive Options

Saline or hypertonic nasal sprays can be added to standard treatment but are significantly less effective than INCS 4, 5. Hypertonic sprays show modest benefit over isotonic saline for symptom scores and quality of life 5.

Clinical Algorithm

1. Start with INCS (fluticasone, triamcinolone, or budesonide) for all patients with moderate-to-severe symptoms
2. If nasal congestion is severe, consider 2-3 days of decongestant spray to facilitate INCS penetration
3. If inadequate response after 1-2 weeks, add intranasal antihistamine (azelastine) if available OTC, or consider prescription combination product
4. Counsel patients about the delayed onset of INCS (days, not hours) to prevent premature discontinuation

The 2024-2025 ARIA guidelines continue to emphasize INCS as the cornerstone of treatment, with combination INAH+INCS reserved for inadequate responders 6.